Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K FABER

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
Acta Endocrinologica|November 1, 1980
Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatmentS Madsbad, T Krarup, L Regeur, et al.
Diabetologia|May 1, 1978
The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitusB M Frier, O K Faber, C Binder, et al.
Acta Endocrinologica|June 1, 1978
HLA antigens in a family with maturity-onset type diabetes mellitusO K Faber, M Thomsen, C Binder, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1989
Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetesH J Gjessing, L E Matzen, O K Faber, et al.
Diabetologia|May 1, 1989
Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetesH J Gjessing, L E Matzen, O K Faber, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1981
Decreased insulin removal contributes to hyperinsulinemia in obesityO K Faber, K Christensen, H Kehlet, et al.
The New England Journal of Medicine|February 27, 1997
Withdrawing intensive life-sustaining treatment -- recommendations for compassionate clinical managementH Brody, M L Campbell, K Faber-Langendoen, et al.
Acta Endocrinologica|February 1, 1984
Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitusT Krarup, S Madsbad, L Regeur, et al.
Lancet (London, England)|January 1, 1977
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?D G Johnson, K G Alberti, O K Faber, et al.
The Journal of Clinical Investigation|November 1, 1980
Hepatic extraction and renal production of 3,3'-diiodothyronine and 3',5'-diiodothyronine in manJ Faber, O K Faber, B Lund, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
Acta Endocrinologica|November 1, 1980
Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatmentS Madsbad, T Krarup, L Regeur, et al.
Diabetologia|May 1, 1978
The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitusB M Frier, O K Faber, C Binder, et al.
Acta Endocrinologica|June 1, 1978
HLA antigens in a family with maturity-onset type diabetes mellitusO K Faber, M Thomsen, C Binder, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1989
Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetesH J Gjessing, L E Matzen, O K Faber, et al.
Diabetologia|May 1, 1989
Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetesH J Gjessing, L E Matzen, O K Faber, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1981
Decreased insulin removal contributes to hyperinsulinemia in obesityO K Faber, K Christensen, H Kehlet, et al.
The New England Journal of Medicine|February 27, 1997
Withdrawing intensive life-sustaining treatment -- recommendations for compassionate clinical managementH Brody, M L Campbell, K Faber-Langendoen, et al.
Acta Endocrinologica|February 1, 1984
Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitusT Krarup, S Madsbad, L Regeur, et al.
Lancet (London, England)|January 1, 1977
Hyperinsulinism of hepatic cirrhosis: Diminished degradation or hypersecretion?D G Johnson, K G Alberti, O K Faber, et al.
The Journal of Clinical Investigation|November 1, 1980
Hepatic extraction and renal production of 3,3'-diiodothyronine and 3',5'-diiodothyronine in manJ Faber, O K Faber, B Lund, et al.
Pageof 16